衡欣品牌怎么样 申请店铺

更新时间:2024-10-29
衡欣是哪个国家的品牌?「衡欣」是 哈尔滨美华生物技术股份有限公司 旗下著名品牌。该品牌发源于黑龙江省哈尔滨市,在2002年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
衡欣怎么样

专业从事微生态制剂、功能性食品、乳制品、乳制品添加剂等生物技术产品领域,国内规模较大的益生菌研发、生产、经营的企业


哈尔滨美华生物技术股份有限公司(以下简称哈美华生物)创建于2002年初,是专注于研发和生产微生态制剂、改善人类健康为己任的股份制企业。哈美华生物生产基地坐落于中国哈尔滨市的西部,这里气候寒冷,空气清爽,远离市区,非常适宜微生态制品的研发、生产。 哈美华生物占地面积3万平方米,建筑面积近1万平方米;具有高起点、高标准的多条生产线,是目前国内规模化、专业化的大型益生菌研发、生产企业。 哈美华生物实行董事会领导下的总经理负责制,建立了完善的企业职能体系和管理制度。生产管理严格按质量体系认证标准规范运行,从而形成了内部质量保障体系。

公司与中科院微生物研究所、中国农大、东北农大、哈尔滨商大食品学院及北京林大生物工程学院等国内科研院校建立了技术合作平台,在生物工程、工艺技术领域密切合作、共同研发,为公司的微生物制品技术持续发展和不断升级奠定了雄厚基础。公司还专门成立了生物工程技术研究所,从事微生态制剂、功能性食品、乳制品、乳制品添加剂等生物技术产品的研发和技术更新,不断为中国自有微生物技术的发展和持续成长开拓创新。 公司还提供可广泛用于乳品工业、保健食品工业、食品和医药企业使用的乳糖酶、稳定剂等系列高科技产品。公司将持续不断的努力研发新品,使我们的产品为广大客户带来更佳的效益。 哈美华生物始终坚持“以人才为核心,技术为保障,提供高标准的优质产品和专业的解决方案,以满足客户发展为目标,以造福人类健康为己任”。


Harbin Meihua Biotechnology Co., Ltd. (hereinafter referred to as hamihua Biology), a large-scale probiotic R & D, production and operation enterprise in China, was founded in early 2002. It is a share dedicated to R & D and production of microecological preparations and improvement of human health Share enterprises. Harbin Meihua biological production base is located in the west of Harbin City, China. The climate here is cold and the air is fresh. It is far away from the city. It is very suitable for the research, development and production of micro ecological products. Hami bio occupies an area of 30000 square meters and a building area of nearly 10000 square meters. It has a high starting point and high standard production lines, and is a large-scale and specialized probiotic research and development and production enterprise in China. Hami bio implements the general manager responsibility system under the leadership of the board of directors, and has established a perfect enterprise function system and management system. Production management operates in strict accordance with the quality system certification standards, thus forming an internal quality assurance system. The company has established a technical cooperation platform with the Institute of Microbiology of Chinese Academy of Sciences, China Agricultural University, Northeast Agricultural University, Harbin Commercial University Food College, Beijing Forestry University Bioengineering College and other domestic scientific research institutions, and has closely cooperated and jointly developed in the fields of bioengineering and process technology, laying a solid foundation for the continuous development and upgrading of the company's microbial products technology. The company has also set up a bioengineering technology research institute, which is engaged in the R & D and technology update of biotechnology products such as microecological agents, functional foods, dairy products, dairy additives, etc., and constantly develops and innovates for the development and sustainable growth of China's own microbial technology. The company also provides a series of high-tech products, such as lactase and stabilizer, which can be widely used in dairy industry, health food industry, food and pharmaceutical enterprises. The company will continue to work hard to develop new products, so that our products for our customers to bring better benefits. Hami bio always adheres to the principle of "taking talents as the core, technology as the guarantee, providing high standard high-quality products and professional solutions, aiming at satisfying the development of customers and benefiting human health".

本文链接: https://brand.waitui.com/572600437.html 联系电话:0451-83087771

千城特选小程序码

7×24h 快讯

东方雨虹:拟5亿元-10亿元回购股份用于注销

36氪获悉,东方雨虹公告,拟5亿元-10亿元回购股份,用于注销并减少公司注册资本。回购价格不超过19.30元/股。

39分钟前

美股大型科技股盘前普涨,谷歌涨超2%

36氪获悉,美股大型科技股盘前普涨,截至发稿,谷歌涨超2%,英伟达、亚马逊、Meta涨超1%,微软涨0.91%,特斯拉涨0.53%,苹果涨0.51%。

39分钟前

热门中概股美股盘前普涨,B站涨超4%

36氪获悉,热门中概股美股盘前普涨,截至发稿,B站涨超4%,小鹏汽车涨超3%,爱奇艺、蔚来涨超2%,阿里巴巴、京东、拼多多、百度涨超1%。

39分钟前

2连板申科股份:近期公司经营情况正常,内外部经营环境未发生重大变化

36氪获悉,申科股份公告,公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息。近期公司经营情况正常,内外部经营环境未发生重大变化。公司10月24日公告,公司控股股东、实际控制人何全波拟将其持有公司全部股份42187466股股权(无限售流通股,占公司总股本的28.12%)股份以公开征集意向受让方方式进行协议转让。

39分钟前

2024年10月票房破35亿

36氪获悉,据灯塔专业版,截止10月28日20时48分,2024年10月总票房(含预售)突破35亿,《志愿军:存亡之战》《浴火之路》《749局》暂列票房前三位。​​​

39分钟前

本页详细列出关于衡欣的品牌信息,含品牌所属公司介绍,衡欣所处行业的品牌地位及优势。
咨询